Kirin Holdings Co (KNBWY) AI Stock Analysis

• Market Cap: $10.95B
• Dividend Yield: 2.47%
• Average Volume (3M): 2.25K
• Price to Earnings (P/E): 29.5
• Beta (1Y): -0.05
• Revenue Growth: 3.38%
• EPS Growth: -59.77%
• Country: US
• Employees: 31,934
• Sector: Consumer Defensive
• Sector Strength: 55
• Industry: Beverages - Alcoholic
• EPS (TTM): 0.20
• Shares Outstanding: 914,000,000
• 10 Day Avg. Volume: 1,677
• 30 Day Avg. Volume: 2,245
• PEG Ratio: -10.59
• Price to Book (P/B): 1.46
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 91.21
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $15.50
• Price Target Upside: 14.90% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 64 Neutral
• Price Target: $15.50 ▲(14.90%Upside)

Kirin Holdings Co's overall score is primarily influenced by solid financial performance, despite challenges in net profitability and free cash flow growth. The technical analysis indicates potential bearish trends, while the high P/E ratio suggests overvaluation concerns. The company's dividend yield provides some compensation for the high valuation.

Kirin Holdings Co Business Overview & Revenue Model

Company Description

Kirin Holdings Company, Limited produces and sells alcoholic beverages, soft drinks, pharmaceuticals, and other related products in Japan and internationally. It operates through four segments: Japan Beer and Spirits Businesses, Japan Non-Alcoholic Beverages Business, Oceania Integrated Beverages Business, and Pharmaceuticals Business. The company's products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, and sake and other food products; as well as manufacture and supply of Four Roses bourbon; and acts as an insurance agent. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Kirin Holdings Co. generates revenue primarily through the production and sale of its beverage products, which include beer, spirits, and a wide range of non-alcoholic drinks. The company's alcohol business, particularly its beer segment, remains a significant contributor to its earnings, with strong brand recognition and a broad distribution network enhancing its market presence. Additionally, Kirin's non-alcoholic beverage segment, comprising soft drinks, tea, and coffee, provides a steady revenue stream, catering to diverse consumer preferences. The company's pharmaceutical and health science division also contributes to its income, focusing on innovative drug development and health-related products. Kirin's strategic partnerships and joint ventures, such as those with other global beverage companies, further bolster its revenue by expanding its product reach and market penetration.

Kirin Holdings Co Financial Statement Overview

Summary

Kirin Holdings Co demonstrates solid revenue growth and operational efficiency, although net profitability is under pressure due to rising costs or interest expenses. The balance sheet shows a stable financial structure with a reasonable level of leverage. However, a decline in free cash flow growth is a concern.

Income Statement

Kirin Holdings Co has shown a consistent increase in revenue over the years, with the most recent year seeing a growth of approximately 9.6%. The gross profit margin is strong at 45.6%, indicating efficient cost management. However, the net profit margin is relatively lower at 2.5% due to increased expenses or interest costs affecting net income. EBIT and EBITDA margins are stable, reflecting solid operational performance.

Balance Sheet

The company's debt-to-equity ratio stands at 0.73, which is reasonable and suggests moderate leverage. The equity ratio is 35.2%, indicating a healthy balance between debt and equity financing. Return on equity (ROE) is 4.9%, which is modest and suggests room for improvement in generating returns on shareholder investments.

Cash Flow

Free cash flow has decreased from the previous year, impacting overall cash flow health. The operating cash flow to net income ratio is strong at 4.2, indicating effective cash generation relative to net income. However, the free cash flow to net income ratio has decreased, signaling potential challenges in maintaining free cash flow levels.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.34T	2.13T	1.99T	1.82T	1.85T
Gross Profit	1.07T	963.47B	905.71B	822.84B	803.88B
EBITDA	253.42B	294.80B	251.27B	227.59B	215.18B
Net Income	58.21B	112.70B	111.01B	59.79B	99.84B
Balance Sheet
Total Assets	3.35T	2.87T	2.54T	2.47T	2.46T
Cash, Cash Equivalents and Short-Term Investments	127.19B	140.34B	96.44B	157.40B	169.62B
Total Debt	857.57B	656.40B	523.12B	551.47B	642.64B
Total Liabilities	1.82T	1.44T	1.29T	1.32T	1.36T
Stockholders Equity	1.18T	1.13T	980.02B	894.18B	838.58B
Cash Flow
Free Cash Flow	62.26B	89.40B	37.08B	132.97B	71.81B
Operating Cash Flow	242.84B	203.21B	135.56B	219.30B	164.84B
Investing Cash Flow	-329.38B	-226.09B	-10.40B	-56.41B	-115.98B
Financing Cash Flow	58.13B	35.91B	-167.84B	-180.46B	-52.47B

Kirin Holdings Co Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 13.49
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KNBWY, the sentiment is Negative. The current price of 13.49 is below the 20-day moving average (MA) of 13.91, below the 50-day MA of 14.27, and below the 200-day MA of 13.96, indicating a bearish trend. The MACD of -0.21 indicates Positive momentum. The RSI at 34.25 is Neutral, neither overbought nor oversold. The STOCH value of 1.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KNBWY.

Kirin Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BUD	79 Outperform	$133.81B	23.13	7.31%	1.55%	0.58%	9.94%
ABEV	75 Outperform	$37.51B	14.47	15.09%	3.73%	1.25%	-13.02%
CCU	73 Outperform	$2.40B	13.62	11.33%	3.36%	6.18%	61.39%
FMX	65 Neutral	$20.75B	21.53	9.84%	1.81%	-0.37%	40.63%
TAP	65 Neutral	$10.15B	10.05	7.90%	3.76%	-5.17%	-0.74%
KNBWY	64 Neutral	$10.95B	29.47	4.91%	2.47%	3.38%	-59.77%
Sector *	61 Neutral	HK$19.79B	11.88	0.81%	5.13%	2.72%	-47.45%